Sun Pharma Q3 profit jumps 16% YoY as branded and innovative businesses drive growth
Sun Pharma on Saturday reported a 15% increase in its third quarter sales to Rs 15,469 crore, while net profit was up 16% year-on-year to Rs 3,368 crore, driven by growth across its branded businesses in India, emerging markets and global innovative medicines. “Our innovative product offering has expanded further with the launch of Unloxcyt…